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Background
Hypoplastic left heart syndrome (HLHS) is a congenital
heart defect in which the left ventricle of the heart is
severely underdeveloped. Applying patient-specific
induced pluripotent stem cells (iPSC) with high-
throughput sequencing technology in RNA-seq and
whole genome sequencing (WGS) provides an unprece-
dented opportunity to investigate the disease-specific
transcription profiles linked to potential genetic causes
in HLHS. Bioengineered HLHS patient-specific iPSCs
and differentiated cardiac tissues offer a platform to
recapitulate the individual developmental process to
study the molecular causes of the disease.
Materials and methods
In this study we reprogrammed the skin fibroblasts from
proband and parents into iPSCs that were subsequently
differentiated towards beating cardiomyocytes. We
performed the RNA-seq on iPSCs and differentiated cardi-
omyocytes. Whole genome sequencing was done on blood
samples from proband and parents. Combining expression
differences between patient-specific cells with genomic
mutations, we analyzed and integrated all these data to
identify the potential genes related to HLHS.
Results
We have identified 4000 and 6000 differential genes
between the family members in iPSC and differentiated
cells respectively. Most the differential genes show a high
expression pattern in iPSC from proband. However, the
pattern from differentiated cells showed both high and
low expression in proband compared with parent.
40 genes with different types of mutations, including
compound heterozygosity, X-linked, de novo mutations,
were identified from whole genome sequencing data.
LRP2 and PRTG were low expressed in proband in iPSC
and differentiated cells and high expressed in the early
heart developmental stages. However, DHCR24 were
highly expressed in proband in both iPSC and differen-
tiated beating cells and also highly expressed in the early
stage of embryogenesis. Furthermore, MYLK, a later
expressed gene in natural cardiogenic roadmap, is also
highly expressed in proband.
Conclusions
By integrating the data from WGS, RNA-seq, and the
naturally expressed time-course developmental roadmap,
we triangulated a list of prioritized candidate genes that
may contribute to HLHS and could be a target for
future mechanistic studies for disease-specific clinical
applications.
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